Lack of an association between vitamin D receptor bsmi gene polymorphism and the risk of end-stage renal disease: A meta-analysis

Internal Medicine

Volumn 52, Issue 21, 2013, Pages 2423-2430

  Mao, Song ^a   Huang, Songming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

BsmI; End stage renal disease; Gene polymorphism; Meta analysis; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ALLELE; ARTICLE; ASIAN; BSMI GENE; CAUCASIAN; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HUMAN; KIDNEY FAILURE; META ANALYSIS; RISK ASSESSMENT;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84887085984     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0866     Document Type: Article

References (36)

1. Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y, Sakhuja V. Treatment of chronic hepatitis C in end stage renal disease: experience at a tertiary care centre. Trop Gastroenterol 33: 189-192, 2012.
2. McDonald SP, Tong B. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy. Nephrology (Carlton) 16: 758-766, 2011.
3. Luke RG. Can we prevent end-stage renal disease due to hypertension or to diabetes mellitus?. JAMA 268: 3119-3120, 1992.
4. Trabulus S, Guven GS, Altiparmak MR, et al. DNA repair XRCC 1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Mol Biol Rep 39: 6995-7001, 2012.
5. Prakash S, Prasad N, Sharma RK, Faridi RM, Agrawal S. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease. Cytokine 58: 261-266, 2012.
6. George GP, Mittal RD. Genetic polymorphisms in MHC-encoded antigen processing gene TAP2: a case-control study in end-stage renal disease patients of North India. Transpl Immunol 24: 220-223, 2011.
7. Borkar M, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S. Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease. Inflamm Res 60: 399-407, 2011.
8. Dusilová Sulková S. Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure. Vnitr Lek 58: 839-849, 2012.
9. Feldman D, Malloy PJ, Gross C, Vitamin D. Biology, action and clinical implications. In: Osteoporosis. 1. Marcus R, Feldman D, Kelsey J, Eds. Academic Press, San Diego, 2001: 257-304.
10. El-Shehaby AM, El-Khatib MM, Marzouk S, Battah AA. Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients. Scand J Clin Lab Invest 73: 75-81, 2013.
11. Akcay A, Ozdemir FN, Sezer S, et al. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Perit Dial Int 3: S52-S55, 2005.
12. Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol 8: 1546-1552, 1997.
13. Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S. Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail 32: 969-977, 2010.
14. Testa A, Mallamaci F, Benedetto FA, et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res 25: 313-319, 2010.
15. Wu HC, Bao YS, Xie RJ. Relationship between vitamin D receptor gene polymorphism and secondary hyperparathyroidism in patients with chronic renal failure. Journal of Harbin Medical University 38: 269-271, 2004 (in Chinese).
16. Wang XY, Zhao WH. Association between vitamin D receptor gene polymorphism and secondary hyperparathyrodism in Chinese with chronic renal failure. J Nephrol Dialy Transplant 8: 124-202, 1999 (in Chinese).
17. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of transacting factor alleles to normal physiological variability: Vitamin D receptor gene polymorphisms and circulating osteoclacin. Proc Natl Acad Sci 89: 6665-6669, 1992.
18. Shahbazi S, Alavi S, Majidzadeh-A K, Ghaffarpour M, Soleimani A, Mahdian R. BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol 30: 393-397, 2013.
19. Gündüz M, Caci{dotless}na C, Toptaş B, Yayli{dotless}m-Eraltan İ, Tekand Y, İsbir T. Association of vitamin D receptor gene polymorphismswith colon cancer. Genet Test Mol Biomarkers 16: 1058-1061, 2012.
20. Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol 18: 1672-1679, 2012.
21. Ismail S, Erfan M, Abd Ei-Salam M, Kamal S, Ibrahim S, Nasr H. Vitamin D receptor gene polymorphism and growth pattern in Egyptian rachitic children. Life Sci J 8: 120-131, 2011.
22. Laaksonen M, Kärkkäinen M, Outila T, Vanninen T, Ray C, Lamberg-Allardt C. Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal women: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, withadjustment for lifestyle factors. J Bone Miner Metab 20: 383-390, 2002.
23. Gezen-Ak D, Dursun E, Bilgiç B, et al. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med 228: 189-196, 2012.
24. Ozdemir FN, Sezer S, Atac B, et al. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc 37: 2922-2924, 2005.
25. Rezende VB, Sandrim VC, Palei AC, et al. Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy. Mol Biol Rep 39: 10903-10906, 2012.
26. Vedralová M, Kotrbova-Kozak A, Zelezníková V, Zoubková H, Rychlík I, Cerná M. Polymorphisms in the vitamin D receptor gene and parathyroid hormone gene in the development and progression of diabetes mellitus and its chronic complications, diabetic nephropathy and non-diabetic renal disease. Kidney Blood Press Res 36: 1-9, 2012.
27. Luo XY, Yang MH, Wu FX, et al. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21: 53-59, 2012.
28. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007.
29. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168: 1629-1637, 2008.
30. Ali FN, Arguelles LM, Langman CB, Price HE. Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic. Pediatrics 123: 791-796, 2009.
31. Petchey WG, Hickman IJ, Prins JB, Hawley CM, Johnson DW, Isbel NM. Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Nephrology (Carlton) 18: 26-35, 2013.
32. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6: 50-62, 2011.
33. Doorenbos CR, van den Born J, Navis G, de Borst MH. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 5: 691-700, 2009.
34. Damasiewicz MJ, Magliano DJ, Daly RM, et al. 25-Hydroxyvitamin D levels and chronic kidney disease in the Aus-Diab (Australian Diabetes, Obesity andLifestyle) study. BMC Nephrol 13: 55, 2012, DOI: 10.1186/1471-2369-13-55
35. Wang Q, Xi B, Reilly KH, Liu M, Fu M. Quantitative assessment of the associations between four polymorphisms (FokI, ApaI, BsmI, TaqI) of vitamin D receptor gene and risk of diabetes mellitus. Mol Biol Rep 39: 9405-9414, 2012.
36. Li L, Wu B, Liu JY, Yang LB. Vitamin D receptor gene polymorphisms and type 2 diabetes: A meta-analysis. Arch Med Res 2013, DOI: 10.1016/j.arcmed.2013.02.002